'''鉀離子通道開放劑'''(英文：Potassium channel opener)是一種促進[[離子|離子]]通過[[鉀離子通道|鉀離子通道]]傳輸的[[藥物|藥物]]。

==例子==
一些示例包括：
*[[二氮嗪|二氮嗪]]<ref name="pmid16159820">{{cite journal|vauthors=Mizutani S, Prasad SM, Sellitto AD, Schuessler RB, Damiano RJ, Lawton JS|date=August 2005|title=Myocyte volume and function in response to osmotic stress: observations in the presence of an adenosine triphosphate-sensitive potassium channel opener|url=https://www.ahajournals.org/doi/full/10.1161/CIRCULATIONAHA.104.523746|journal=Circulation|volume=112|issue=9 Suppl|pages=I219–23|doi=10.1161/CIRCULATIONAHA.104.523746|pmid=16159820|doi-broken-date=2021-01-14}}</ref>
*[[米諾地爾|米諾地爾]]<ref name="pmid12538840">{{cite journal|author=Wang T|date=February 2003|title=The effects of the potassium channel opener minoxidil on renal electrolytes transport in the loop of henle|url=https://archive.org/details/sim_journal-of-pharmacology-and-experimental-therapeutics_2003-02_304_2/page/833|journal=J. Pharmacol. Exp. Ther.|volume=304|issue=2|pages=833–40|doi=10.1124/jpet.102.043380|pmid=12538840|s2cid=6948410}}</ref>
*[[尼可地爾|尼可地爾]]<ref name="pmid18981577">{{cite journal|vauthors=Sudo H, Yogo K, Ishizuka N, Otsuka H, Horie S, Saito K|date=November 2008|title=Nicorandil, a potassium channel opener and nitric oxide donor, improves the frequent urination without changing the blood pressure in rats with partial bladder outlet obstruction|journal=Biol. Pharm. Bull.|volume=31|issue=11|pages=2079–82|doi=10.1248/bpb.31.2079|pmid=18981577|doi-access=free}}</ref>
*[[吡那地爾|吡那地爾]]<ref name="pmid17538231">{{cite journal|vauthors=Stojnic N, Gojkovic-Bukarica L, Peric M, etal|date=June 2007|title=Potassium channel opener pinacidil induces relaxation of the isolated human radial artery|journal=J. Pharmacol. Sci.|volume=104|issue=2|pages=122–9|doi=10.1254/jphs.FP0061434|pmid=17538231|doi-access=free}} {{dead link|date=May 2010}}</ref>
*[[瑞替加濱|瑞替加濱]],<ref name="pmid9384239">{{cite journal|author=Rundfeldt C|date=October 1997|title=The new anticonvulsant retigabine (D-23129) acts as an opener of K+ channels in neuronal cells|journal=European Journal of Pharmacology|volume=336|issue=2–3|pages=243–9|doi=10.1016/S0014-2999(97)01249-1|pmid=9384239}}</ref><ref name="pmid10908292">{{cite journal|vauthors=Main MJ, Cryan JE, Dupere JR, Cox B, Clare JJ, Burbidge SA|date=August 2000|title=Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine|journal=Molecular Pharmacology|volume=58|issue=2|pages=253–62|doi=10.1124/mol.58.2.253|pmid=10908292}}</ref>
*[[氟吡汀|氟吡汀]]

==參見==
*[[鉀離子通道阻斷劑|鉀離子通道阻斷劑]]

==參考資料==
{{Reflist}}

{{Neuromodulation}}

[[Category:鉀離子通道開放劑|Category:鉀離子通道開放劑]]